FSHD patients show a loss of repressive epigenetic marks at the D4Z4 repeats [7,8,9], correlated with disease severity [10,11] and leading to the aberrant expression of DUX4 in muscles. This evidence concerns the gene DUX4 and Facioscapulohumeral dystrophy.